A384470 Stock Overview
Coreline Soft, Co., Ltd. develops medical software to provide diagnosis and image solution for lung diseases. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Coreline Soft Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩7,340.00 |
52 Week High | ₩32,700.00 |
52 Week Low | ₩6,240.00 |
Beta | 0.69 |
11 Month Change | -5.53% |
3 Month Change | -17.44% |
1 Year Change | -61.37% |
33 Year Change | -33.22% |
5 Year Change | n/a |
Change since IPO | -32.07% |
Recent News & Updates
Shareholder Returns
A384470 | KR Healthcare Services | KR Market | |
---|---|---|---|
7D | 5.0% | 23.4% | -2.8% |
1Y | -61.4% | -37.7% | -3.4% |
Return vs Industry: A384470 underperformed the KR Healthcare Services industry which returned -37.7% over the past year.
Return vs Market: A384470 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
A384470 volatility | |
---|---|
A384470 Average Weekly Movement | 6.0% |
Healthcare Services Industry Average Movement | 7.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in KR Market | 11.5% |
10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A384470 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A384470's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 105 | n/a | www.corelinesoft.com |
Coreline Soft, Co., Ltd. develops medical software to provide diagnosis and image solution for lung diseases. It offers AVIEW Metric-Lung, a quantitative image biomarker software of COPD using chest CT images; AVIEW Modeler, a three-dimensional (3D) modeling software for 3D printing; and AVIEW Research, a software for medical research data management. The company was founded in 2012 and is based in Seoul, South Korea.
Coreline Soft Co., Ltd. Fundamentals Summary
A384470 fundamental statistics | |
---|---|
Market cap | ₩94.18b |
Earnings (TTM) | -₩14.66b |
Revenue (TTM) | ₩4.42b |
21.3x
P/S Ratio-6.4x
P/E RatioIs A384470 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A384470 income statement (TTM) | |
---|---|
Revenue | ₩4.42b |
Cost of Revenue | ₩0 |
Gross Profit | ₩4.42b |
Other Expenses | ₩19.08b |
Earnings | -₩14.66b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.14k |
Gross Margin | 100.00% |
Net Profit Margin | -331.33% |
Debt/Equity Ratio | 89.8% |
How did A384470 perform over the long term?
See historical performance and comparison